1702. Assessing the Safety and Efficacy of Valganciclovir Dosing for Cytomegalovirus Prophylaxis in Solid Organ Transplant Recipients on Hemodialysis

BACKGROUND: Valganciclovir is the standard of care used for the prevention of Cytomegalovirus (CMV) infections among solid organ transplant (SOT) recipients. Currently there is minimal guidance for prophylaxis in SOT recipients undergoing intermittent hemodialysis (IHD). At Mount Sinai Hospital (MSH...

Descripción completa

Detalles Bibliográficos
Autores principales: Yee, Jason, Saunders-Hao, Patricia, Miko, Leandra, Rana, Meenakshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777776/
http://dx.doi.org/10.1093/ofid/ofaa439.1880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777776/
http://dx.doi.org/10.1093/ofid/ofaa439.1880

Ejemplares similares